Ifytrox TB 1000mg/125mg Injection
Marketer
Syntonic Lifesciences
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Ifytrox TB 1000mg/125mg Injection
Combiflox TB Injection (1000mg/125mg) is a dual-action medication used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby limiting infection spread. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire treatment course, regardless of symptom improvement. Premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress). Inform your physician of all concurrent medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential for increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Ample rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order lab tests to monitor the medicine's impact.
Primary Ingredients of Ifytrox TB 1000mg/125mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Ifytrox TB 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox TB 1000mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ifytrox TB 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ifytrox TB 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider; please refrain from self-medication.
How Ifytrox TB 1000mg/125mg Injection works:
Each Ifytrox TB 1000mg/125mg injection contains ceftriaxone, a broad-spectrum antibiotic, and tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Tazobactam counters bacterial resistance mechanisms, thus bolstering ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Ifytrox TB 1000mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox TB (1000mg/125mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Ifytrox TB 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ifytrox TB 1000mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ifytrox TB 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Ifytrox TB 1000mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Ifytrox TB 1000mg/125mg Injection isn't advised for individuals with mild or moderately impaired liver function.
What if you forget to take Ifytrox TB 1000mg/125mg Injection :
Omit a dose of Ifytrox TB 1000mg/125mg Injection? Seek your physician's advice.
Facts to Know About Ifytrox TB 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently